The World of Health & Medicine News

Gates Foundation to commit $1.6 billion for Gavi vaccine alliance

Gates Foundation to commit $1.6 billion for Gavi vaccine alliance

The Gates Foundation said on Tuesday it will commit $1.6 billion over the next five years to support Gavi, a public-private partnership that helps buy vaccines for the world’s poorest children.

The number of kids dying around the world will likely go up this year because of the massive cuts to foreign aid, foundation chair Bill Gates said in a statement, adding that funding Gavi was the single most powerful step to stop it.

The vaccine alliance is looking to raise $9 billion for its work from 2026 to 2030 at a pledging event to be held in Brussels on Wednesday. It is co-hosted by the European Union and the Gates Foundation.

The Trump administration has previously indicated that it planned to cut its funding for Gavi, representing around $300 million annually.

Losing U.S. funding could lead to around 1.2 million additional deaths over the next five years, Gavi CEO Sania Nishtar had said.

The alliance works along with governments to fund the purchase of vaccines to prevent deadly diseases such as measles and diphtheria.

spot_img

Explore more

spot_img

US FDA approves Gilead’s twice-yearly injection for HIV prevention

US FDA approves Gilead's twice-yearly injection for HIV prevention The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences (GILD.O), opens new tab lenacapavir, a twice-yearly...

WHO says ‘no evidence of harm’ from thimerosal

WHO says 'no evidence of harm' from thimerosal The World Health Organization said on Friday that thimerosal, a mercury-preservative used in some vaccines was not...

Tobacco control efforts protect 6.1 billion people – WHO’s new report

Tobacco control efforts protect 6.1 billion people – WHO’s new report The World Health Organization (WHO) today released its report on the Global Tobacco Epidemic 2025 at...

NHS makes major change to cervical cancer screenings for younger women

NHS makes major change to cervical cancer screenings for younger women Women aged 25 to 49 who test negative for human papillomavirus (HPV) will be...

Remarkable efficacy and acceptable safety of Lilly’s oral drug Orforglipron

Remarkable efficacy and acceptable safety of Lilly's oral drug Orforglipron Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1...

Metsera rises as experimental weight-loss drug shows promise in small early-stage...

Metsera rises as experimental weight-loss drug shows promise in small early-stage trial Shares of weight-loss drug developer Metsera (MTSR.O), opens new tab gained as much as 25%...

More than 11% weight loss with experimental drug Eloralintide in early...

More than 11% weight loss with experimental drug Eloralintide in early stages of trial Eli Lilly's experimental drug Eloralintide helps some patients lose more than...

FDA approves AstraZeneca and Daiichi Sankyo’s Datroway for NSCLC

FDA approves AstraZeneca and Daiichi Sankyo’s Datroway for NSCLC The US Food and Drug Administration (FDA) has approved AstraZeneca and Daiichi Sankyo's Datroway (Datopotamab deruxtecan)...